CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Perrigo Company PLC Company Snapshot
Perrigo Company PLC operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Perrigo Company PLC with three other companies in this sector in UNITED STATES : Alexion Pharmaceuticals, Inc. (2019 sales of $4.95 billion of which 80% was Soliris), Vertex Pharmaceuticals Inc ($4.16 billion of which 100% was Pharmaceuticals), and Eisai Company Limited ($5.79 billion of which 88% was Pharmaceutical Business).

Sales Analysis. During the year ended December of 2019, sales at Perrigo Company PLC were $4.84 billion. This is an increase of 2.2% versus 2018, when the company's sales were $4.73 billion. Despite this increase, sales are still below the level achieved in 2017, when Perrigo Company PLC reported sales of $4.95 billion. Sales of Csca saw an increase of 3.2% in 2019, from $2.41 billion to $2.49 billion. Not all segments of Perrigo Company PLC experienced an increase in sales in 2019: sales of Csci fell 7.6% to $1.38 billion.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Perrigo Company PLC
  Stock Performance Chart for Perrigo Company PLC
 
  Stock Data: Recent Stock Performance:
  Current Price (9/11/2020): 48.62
(Figures in U.S. Dollars)
1 Week -4.4%   13 Weeks -9.0%  
4 Weeks -5.6%   52 Weeks -13.1%  
 
Perrigo Company PLC Key Data:
  Ticker: PRGO Country: Ireland
  Exchanges: NAS FRA TEL Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 4,837,400,000
(Year Ending Jan 2020).
Employees: 11,200
  Currency: U.S. Dollars Market Cap: 6,636,630,000
  Fiscal Yr Ends: December Shares Outstanding: 136,500,000
  Share Type: Common Closely Held Shares: 1,034,063
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.